BioWorld

June 26, 2003

View Archived Issues

Sending Off Bone Marrow, Stem Cells, Umbilical Cord To Enrich Cancer, Transplant Procedures

Inex's NHL Drug Proves Strong In Final Phase II/III Study Data

Zealand, Aventis Enter $100M Pact To Develop Diabetes Drug

SuperGen Brings In $21.25M Via Private Sale Of Convertible Notes

Novartis Buys Overseas Rights To Genentech's AMD Therapy

The Day At BIO 2003: Protesters Chose To Take Conference Off

Other News To Note

BIO 2003 Ends With Optimism, More Biotech Political Awareness

Only 10 years ago at the Biotechnology Industry Organization's first annual convention in Raleigh and Research Triangle Park, N.C., about 1,400 people attended. Read More

Sessions On Generic Biologics Show Prospect Is Gaining Steam

Today's news in brief

BioWorld

BioWorld briefs for Jan 28, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 28, 2026.

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

Muted and missing M&As: JPM deals absent in 2026

BioWorld

For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...